Abstract
Background and objective
To analyze the relationship between brain MRI, clinical symptoms, and cerebrospinal fluid (CSF) and to provide a reference for early diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.
Materials and Methods
A total of 62 patients with anti-NMDAR encephalitis in Zhengzhou, China (2016–2018) were observed and registered prospectively. First, we analyzed the characteristics of clinical symptoms. Second, according to the disease duration, patients were divided into two groups, and then we analyzed the CSF features. In addition, they were divided into two groups according to the brain MRI, and then the CSF features were analyzed. Finally, the characteristics of cerebrospinal fluid in patients with seizure as the initial symptom were analyzed.
Results
Seizure presents as the initial symptom in 14 patients (22.5%), including 11 males (78.57%). The proportion and concentration of CSF total protein abnormalities in the early stage group were significantly higher than those in the middle and late group (P < 0.05). The total protein concentration in the abnormal brain MRI group was significantly higher than that in the normal MRI group (P < 0.05).
Conclusion
Anti-NMDAR encephalitis should be suspected, when male patients complain of seizure as an initial symptom and have simultaneously had headaches or fever prior to onset. The sensitivity of anti-NMDAR antibody is higher in CSF than in serum. Total CSF protein is more prone to elevation in the middle and late stages of anti-NMDAR encephalitis. Brain MRI abnormalities with anti-NMDAR encephalitis are related to the total protein concentration of CSF, which may be related to the disease duration.
Similar content being viewed by others
References
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098. https://doi.org/10.1016/S1474-4422(08)70224-2
Armangue T, Titulaer MJ, Málaga I, Bataller L, Gabilondo I, Graus F, Dalmau J, Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group (2013) Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 162:850–856. https://doi.org/10.1016/j.jpeds
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404. https://doi.org/10.1016/S1474-4422(15)00401-9
Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:an observational cohort study. Lancet Neurol 12:157–165. https://doi.org/10.1016/S1474-4422(12)70310-1
Wang R, Guan HZ, Ren H, Wang W, Hong Z, Zhou D (2015) CSF findings in patients with anti-N-metIlyl-D-aspartate receptor-encephalitis. Seizure 29:137–142. https://doi.org/10.1016/j.seizure.2015.04.005
Deng B, Chen XJ, Li X et al (2016) Analysis of the cerebrospinal fluid abnormalities and their correlation with disease course in patients with anti-N-methyl-D-aspartate receptor encephalitis. Chin J Clin Neurosci 24:528–534
Gastaldi M, Zardini E, Leante R et al (2017) Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci 38:217–224. https://doi.org/10.1007/s10072-017-3034-2
Malter MP, Elger CE, Surges R (2013) Diagnostic value of CSF findings in antibody associated limbic and anti-NMDAR-encephalitis. Seizure 22:136–140. https://doi.org/10.1016/j.seizure.2012.12.013
Reiber H (1998) Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 4:99–107. https://doi.org/10.1177/135245859800400302
Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Öhman S, Racke MK, Sharief M, Sindic CJM, Sellebjerg F, Tourtellotte WW (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62:865–870. https://doi.org/10.1001/archneur.62.6.865
Zuliani L, Zoccarato M, Gastaldi M et al (2017) Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens. Neurol Sci 38:225–229. https://doi.org/10.1007/s10072-017-3032-4
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74. https://doi.org/10.1016/S1474-4422(10)70253-2
Viaccoz A, Desestret V, Ducray F et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563. https://doi.org/10.1093/cid/cir1038
Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor dependent mechanism. J Neurosci 14:7680–7687
Lynch JJ 3rd, Shek EW, Castagne V, Mittelstadt SW (2010) The proconvulsant effects of leptin on glutamate receptor mediated seizures in mice. Brain Res Bull 82:99–103. https://doi.org/10.1016/j.brainresbull.2010.02.003
Pennell PB (2009) Hormonal aspects of epilepsy. Neurol Clin 27:941–965. https://doi.org/10.1016/j.ncl.2009.08.005
Kalkbrenner KA, Standley CA (2003) Estrogen modulation of NMDA-induced seizures in ovariectomized and non-ovariectomized rats. Brain Res 964:244–249. https://doi.org/10.1016/s0006-8993(02)04065-9
Wang Y, Xueqiang H, Xueping Z et al (2013) The clinical significance of cerebrospinal fluid oligoclonal bands for multiple sclerosis. Chin J Neuroimmunol 20:153–155
Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840–851. https://doi.org/10.1056/NEJMra1708712
Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W (2013) Increased prevalence of diverse N -methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 70:1–8. https://doi.org/10.1001/2013.jamapsychiatry.86
Zerche M, Weissenborn K, Ott C, Dere E, Asif AR, Worthmann H, Hassouna I, Rentzsch K, Tryc AB, Dahm L, Steiner J, Binder L, Wiltfang J, Sirén AL, Stöcker W, Ehrenreich H (2015) Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke. Stroke 46:1180–1186. https://doi.org/10.1161/STROKEAHA.114.008323
Busse S, Busse M, Brix B, Probst C, Genz A, Bogerts B, Stoecker W, Steiner J (2014) Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. Eur Arch Psychiatry Clin Neurosci 264:545–550. https://doi.org/10.1007/s00406-014-0493-9
Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stöcker W, Ehrenreich H (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76:82–94. https://doi.org/10.1002/ana.24189
Titulaer MJ, Hoftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75:411–428. https://doi.org/10.1002/ana.24117
Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7:327–340. https://doi.org/10.1016/S1474-4422(08)70060-7
Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36. https://doi.org/10.1002/ana.21050
Acknowledgments
The authors thank the patients for their collaboration.
Funding
This study was supported by the grant from the National Natural Science Foundation of China (81371438) and the National Natural Science Foundation of China (81771397).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The Ethics Committee of the First Affiliated Hospital of Zhengzhou University approved this study (number: KY-2015-51).
Informed consent
All subjects gave their informed consent prior to their inclusion in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(XLSX 20 kb).
Rights and permissions
About this article
Cite this article
Wu, S., Li, H., Lian, Y. et al. Anti-N-methyl-D-aspartate receptor encephalitis: a prospective study focused on cerebrospinal fluid and clinical symptoms. Neurol Sci 41, 3255–3263 (2020). https://doi.org/10.1007/s10072-020-04451-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04451-0